| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$381 |
Imricor Releases FY24 Results
|
27 Feb 2025 8:07AM |
$1.460 |
$1.190 |
fallen by
18.49%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- First module submitted and returned by US FDA with no deficiencies
- NorthStar submitted for CE Mark approval in Europe
- First MRI guided ablation on US soil performed at Johns Hopkins as part of VISABL-AFL
- Saudi FDA approval received, registration completed in Qatar opening Middle East
- CE Mark approval of MR Vision diagnostic catheter
- VISABL-AFL global pivotal trial commences enrolment in France, US and Switzerland
- Global rollout underway with new site activations in France, Netherlands, Croatia and Switzerland
- Installation complete in Hungary, first procedures being scheduled
- First purchase orders received from Qatar initiating expansion into Middle East
- Group revenue of US$959k + 56% on prior year
- Operating costs well contained down 1% to $17.3m including R&D investment
- Strong balance sheet US$15.7m cash in place to fund major milestones in 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IDP Education Limited (IEL) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,002 |
H1 FY25 Results Announcement
|
27 Feb 2025 8:07AM |
$11.790 |
$3.600 |
fallen by
69.47%
|
|
IEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $475.4 million, down 16%
- Adjusted EBIT of $92.7 million, down 40%
- Overhead costs down 14% to $167.8 million
- Student Placement volumes decreased by 27%
- English Language Testing volumes down 24%
- Interim dividend of 9.0 cents per share declared
- Cost discipline and market share growth emphasized
- Long-term growth drivers for international education remain positive
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Change Financial Limited (CCA) ORDINARY FULLY PAID |
Financials |
$58 |
H1 FY25 Investor Presentation
|
27 Feb 2025 8:07AM |
$0.067 |
$0.085 |
risen by
26.87%
|
|
| Change Financial Limited (CCA) ORDINARY FULLY PAID |
Financials |
$58 |
H1 FY25 Results Summary
|
27 Feb 2025 8:07AM |
$0.067 |
$0.085 |
risen by
26.87%
|
|
| IDP Education Limited (IEL) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,002 |
H1 FY 25 Interim Financial Report
|
27 Feb 2025 8:07AM |
$11.790 |
$3.600 |
fallen by
69.47%
|
|
IEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for H1 FY25 decreased by 18% to $475.4 million.
- Net profit after tax fell by 39% to $59.7 million.
- Student placement revenue dropped by 15% to $244.2 million.
- English language testing revenue declined by 22%.
- Revenue decline was attributed to decreased student volumes in major markets.
- Australasia segment recorded a 27% revenue increase.
- Net debt increased to $191 million.
- Cash and cash equivalents at the end of the half-year were $156.9 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$310 |
Update - Notification of buy-back - SVR
|
27 Feb 2025 8:06AM |
$1.440 |
$1.595 |
risen by
10.76%
|
|
| Change Financial Limited (CCA) ORDINARY FULLY PAID |
Financials |
$58 |
Half Yearly Report and Accounts
|
27 Feb 2025 8:06AM |
$0.067 |
$0.085 |
risen by
26.87%
|
|
CCA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 61% to US$7,193,111 for the half year ended 31 December 2024.
- Operating loss for the period was US$1,731,201, an increase of 13% from last year.
- The company aims for over 30% revenue growth and a positive EBITDA in FY25.
- Exit from the US market expected to significantly reduce operating expenses.
- Focus on solidifying client base and building new partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$381 |
Appendix 4E and FY24 Financial Accounts
|
27 Feb 2025 8:06AM |
$1.460 |
$1.190 |
fallen by
18.49%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Imricor Medical Systems Inc focuses on MRI-guided technology for cardiac procedures.
- Total revenues increased to $959,424 in 2024 from $615,568 in 2023.
- The company reported a net loss of approximately $29.69 million for 2024.
- There are concerns regarding the company's ability to continue as a going concern.
- The company has faced recurring operational losses and negative cash flows.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$32,316 |
Update - Notification of buy-back - BXB
|
27 Feb 2025 8:06AM |
$20.980 |
$23.640 |
risen by
12.68%
|
|
| SDI Limited (SDI) ORDINARY FULLY PAID |
Health Care |
$102 |
HY24 Investor Results Presentation
|
27 Feb 2025 8:06AM |
$0.845 |
$0.860 |
risen by
1.78%
|
|
SDI - Price-sensitive ASX Announcement
Full Release
Key Points
- HY25 revenue decreased to $51.5 million.
- Gross profit margin increased to 63.5%.
- Strong growth in European and Brazilian markets.
- Continued investment in operational efficiencies.
- Montrose manufacturing upgrade project underway.
- Launch of new products planned in the next 12 months.
- Commitment to ESG initiatives and reporting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$308 |
H1 FY25 Results & Investor Presentation
|
27 Feb 2025 8:06AM |
$0.370 |
$0.300 |
fallen by
18.92%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- Turnover of $645.1 million, a 116% increase year-on-year.
- Gross Win Margin increased to 14.2%.
- Net Win Margin improved to 10.4%.
- Normalized EBITDA positive ahead of schedule.
- Successful migration from betr platform in 59 days.
- Focus on customer retention and targeted marketing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SDI Limited (SDI) ORDINARY FULLY PAID |
Health Care |
$102 |
Media Release Dec 24 Results
|
27 Feb 2025 8:06AM |
$0.845 |
$0.860 |
risen by
1.78%
|
|
SDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax increased by 3.5% to $3.8 million.
- Sales decreased by 1.3% to $51.5 million.
- Gross product margin improved to 63.5%, an increase of 200 bps.
- Operating expenses rose by 4.3% compared to the previous year.
- Interim ordinary dividend maintained at 1.5 cents per share.
- Sales growth noted in Aesthetic products, particularly Stela.
- Challenges faced in Middle Eastern and Asian markets.
- Focus on achieving manufacturing and logistical efficiencies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$654 |
HY25 Investor Presentation
|
27 Feb 2025 8:06AM |
$0.530 |
$0.395 |
fallen by
25.47%
|
|
PGC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 28% to $1.85 billion for HY25.
- Net profit after tax rose to $13.2 million, an increase of 85.9%.
- Successful merger with CH2 Holdings Pty Ltd completed on 3 June 2024.
- Targeting annual synergies of $5 million for FY25 and $12 million for FY26.
- Operational efficiencies and cost rationalization are key strategic focuses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SDI Limited (SDI) ORDINARY FULLY PAID |
Health Care |
$102 |
Dividend/Distribution - SDI
|
27 Feb 2025 8:06AM |
$0.845 |
$0.860 |
risen by
1.78%
|
|
| SDI Limited (SDI) ORDINARY FULLY PAID |
Health Care |
$102 |
Half Yearly Report and Accounts
|
27 Feb 2025 8:06AM |
$0.845 |
$0.860 |
risen by
1.78%
|
|
SDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax increased by 3.5% to $3.8 million.
- Total sales revenue declined by 1.3% to $51.541 million.
- Gross product margin improved to 63.5%, up 200 bps.
- Earnings per share increased to 3.22 cents.
- Interim fully franked dividend maintained at 1.5 cents per share.
- Sales growth observed in Aesthetic products despite declines in Amalgam sales.
- Challenges faced in Middle Eastern and Asian markets.
- Ongoing investments in production automation and new product development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$308 |
H1 FY25 Results Announcement
|
27 Feb 2025 8:06AM |
$0.370 |
$0.300 |
fallen by
18.92%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- EBITDA positive half delivered ahead of schedule.
- Growth momentum accelerates with acquisition of TopSport.
- Offer to acquire PointsBet for $340-360 million announced.
- Transaction to unlock $40 million in annual synergies.
- Strategic aim for 10% - 15% market share in Australian wagering.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$654 |
HY25 Results Release
|
27 Feb 2025 8:06AM |
$0.530 |
$0.395 |
fallen by
25.47%
|
|
PGC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $1.85 billion up 13.1%
- EBITDA of $47.5 million up 10.5%
- Net Profit After Tax excluding PPA of $16.1 million up 13.3%
- Integration plans on track for merged entity
- Focus on operational efficiency and cost rationalisation
- Continued execution on growth initiatives
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,462 |
Change in substantial holding
|
27 Feb 2025 8:06AM |
$5.850 |
$7.240 |
risen by
23.76%
|
|
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$13 |
Change in substantial holding - Phoenix
|
27 Feb 2025 8:06AM |
$0.039 |
$0.043 |
risen by
10.26%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$308 |
Half Yearly Report & Accounts
|
27 Feb 2025 8:06AM |
$0.370 |
$0.300 |
fallen by
18.92%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue from ordinary activities increased by 122.3% to $62,089,000.
- Net loss reduced significantly to $496,000 compared to $10,363,000 in the prior half-year.
- The company has undertaken acquisitions, including TopSport and plans for PointsBet.
- Total equity rose to $54,676,000, indicating growth in net assets.
- EBITDA stood at $2,031,000, a recovery from the previous year's loss.
- No dividends were paid during the current or previous financial half-year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$654 |
HY25 Appendix 4D and Half Year Report
|
27 Feb 2025 8:06AM |
$0.530 |
$0.395 |
fallen by
25.47%
|
|
PGC - Price-sensitive ASX Announcement
Full Release
Key Points
- Paragon Care's net profit increased to $13.23 million, an 85.8% rise from the previous year.
- Revenue for the half-year reached $1.85 billion, a 28.4% increase.
- The growth is attributed to the acquisition of CH2 Holdings and market share gains.
- Gross margin improved due to a favorable sales mix of higher-margin products.
- The acquisition of CH2 Holdings was treated as a reverse acquisition for accounting purposes.
- Fair value adjustments related to acquisitions are ongoing and expected to finalize by 31 May 2025.
- The company anticipates that finance costs will revert to historical levels in the second half of the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$13 |
Change in substantial holding - NPL
|
27 Feb 2025 8:06AM |
$0.039 |
$0.043 |
risen by
10.26%
|
|
| Sarama Resources Ltd (SRR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$14 |
Sarama Advances Mt Venn Gold Project Acquisition
|
27 Feb 2025 8:05AM |
$0.029 |
$0.038 |
risen by
31.03%
|
|
SRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Binding agreement executed for acquisition of 80% interest in belt-scale Mt Venn Project
- Located in the prolific Laverton Gold District, 35km from the producing Gruyere Gold Mine
- Project covers 420km² and features a favourable litho-structural setting
- Includes regional shear zone of ~50km strike length and 1-3km width
- Advanced gold targets generated through historical exploration
- Highly complementary to Sarama’s recently acquired Cosmo Project
- Creates 1,000km² exploration position in the Laverton Gold District
- Land access agreement with Traditional Owners in place for exploration
- Initial exploration funded by the November 2024 equity raise of A$2M
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orbminco Limited (OB1) ORDINARY FULLY PAID |
Materials |
$3 |
SRR: Sarama Advances Mt Venn Gold Project Acquisition
|
27 Feb 2025 8:05AM |
$0.002 |
$0.001 |
fallen by
50%
|
|
OB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Sarama Resources is acquiring the Mt Venn gold project from Orbminco Limited.
- The transaction is classified as an arm's length acquisition under TSX Venture Exchange Policy.
- Orbminco's subsidiary, Yamarna, holds an 80% interest in the project.
- Completion of the transaction requires several key conditions to be met.
- The project is currently in the exploration phase.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$3,421 |
Change of Director's Interest Notice
|
27 Feb 2025 8:05AM |
$14.130 |
$15.150 |
risen by
7.22%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
